Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Advil PM Liqui-Gels Minis vs Advil PM Liqui-Gels
NCT05674721Phase 1Completed
- Sponsor
- Haleon
- Start
- Jan 2023
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ibuprofen + diphenhydramine hydrochloride in pain and Insomnia (2 arms), sponsored by Haleon. Primary endpoints: Maximum Observed Plasma Concentration for Ibuprofen at Day 11, Maximum Observed Plasma Concentration for Diphenhydramine at Day 11 and 4 more. Started Jan 2023; status: completed.
02
Drugs
ibuprofen + diphenhydramine hydrochloride
03
Conditions
painInsomnia
Beyond the preview
Go deeper on NCT05674721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05674721.